Cold Sores Clinical Trials Cold Sores RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer
Conditions:   Ovarian Cancer;   Peritoneal Carcinomatosis;   Fallopian Tube Cancer Intervention:   Drug: Recombinant oncolytic herpes simplex virus type 1 (R130) Sponsors:   Shanghai Yunying Medical Technology;   Shanghai 10th People's Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 6, 2023 Category: Research Source Type: clinical trials